KOD Overview
Upcoming Projects (KOD)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (KOD)
-
A Second Look: Examining Kodiak Sciences Bi-Specific Clinical Pipeline for Non-Infectious Uveitis and Geographic Atrophy
Tickers: KOD, ALPMF, APLS, ABBV
Executed On: May 23, 2025 at 03:30 PM EDT -
Examining Kodiak Sciences Bi-Specific Clinical Pipeline for Non-Infectious Uveitis and Geographic Atrophy
Tickers: KOD, ALPMF, APLS, ABBV
Executed On: May 22, 2025 at 08:00 AM EDT -
Examining the potential of Kodiak's KSI-501 in patients with Diabetic Macular Edema
Ticker: KOD
Executed On: Sep 26, 2023 at 09:00 AM EDT -
A Second View: Reviewing the current treatment landscape for macular edema, with a focused look at Kodiak Sciences recent phase 3 data on Tarcocimab
Tickers: KOD, REGN
Executed On: Sep 02, 2022 at 10:00 AM EDT -
Reviewing the current treatment landscape for macular edema, with a focused look at Kodiak Sciences recent phase 3 data on Tarcocimab
Tickers: KOD, REGN
Executed On: Aug 29, 2022 at 10:30 AM EDT
Upcoming & Overdue Catalysts (KOD)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (KOD)
-
Phase 1b data of Kodiak's (KOD) KSI-301 in Wet age-related macular degeneration to be presented at ASRS meeting
Ticker: KOD
Occurred on: Jul 27, 2019
Strategic Initiatives (KOD)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
